NCT00209638View on ClinicalTrials.gov

Phase I/II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

May 31, 2000

Study Completion Date

April 30, 2003

Conditions

Gastric Cancer

Interventions

DRUG

irinotecan

DRUG

S-1

All Listed Sponsors

lead

Hokkaido Gastrointestinal Cancer Study Group

OTHER

NCT00209638 - Phase I/II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer | Biotech Hunter | Biotech Hunter